Practice
  • Home
  • News
  • Pin Points
  • Events
  • Programmes
  • Resources
  • About
REFINE YOUR SEARCH
FILTERS
CLEAR FILTERS
Region
Category
Target age
Programmes » Hepatitis C - Tairāwhiti

Hepatitis C

Tairāwhiti | Gastroenterology | Under 18 | Over 18 | Over 65

Overview

A public campaign to eradicate hepatitis C in Tairāwhiti commenced on 25 June 2018.  

Patients identified as being at risk of being hepatitis C positive are able to be screened at a range of service providers. If any of these patients are hepatitis C antibody positive they can then engage with general practice in order to have further testing and possible treatment initiated. 

General practice is supported to identify and test these patients and initiate a treatment plan following a positive diagnosis, to ensure there are no barriers to this group of patients accessing care. 

Your Pinnacle Services Contract applies to this service. By claiming for this service, you have indicated that you have read and agreed to the business rules set out here.  

This is NOT a clinical guideline. 

Details

Which practices can claim for this service?

Any Pinnacle practice in Tairāwhiti can offer and claim for this service. 

Service components

The service funds one initial contact, a maximum of two 30 minute consults and one extended prescriber consult per patient. The flow chart below demonstrates the process.  

The initial contact may be by phone or face to face and includes discussion with the patient about the service and the condition. The antibody test result needs to be recorded. If this has been done elsewhere, the result is still to be recorded on the practice’s patient management system. 

An initial (30 minute) consultation is indicated if the antibody test is positive. This consultation is to include recording of the PCR result and referral to Fibroscan and/or APRI score. 

If treatment is to be initiated in primary care, as indicated following the Fibroscan/APRI score, a prescriber consult (30 minutes) is funded to prescribe treatment.  

If treatment is prescribed, phone calls are required to check adherence and the impact of any side effects. Repeat blood tests are also required. 

A second follow up (30 minute) consultation with the patient is funded 12 weeks after the completion of general practice prescribed treatment. At this consultation, the repeated PCR result is to be recorded. 

NB: Each of these consults are only claimable once per patient and the follow up consult is only for patients who have completed a course of primary care prescribed treatment. 

First contact flow chart

Flowchart illustrating the service components.  

Who is eligible for the service?

Patients who have one of the following risk factors: 

  • ever injected drugs (once is enough) 
  • received a blood transfusion, or blood products, prior to 1992 (in New Zealand) 
  • lived, or received medical treatment, in high-risk countries (South East Asia, China, the Middle East, and Eastern Europe including Russia) 
  • received a tattoo or body piercing using unsterile equipment  
  • ever been in prison 
  • born to a mother infected with hepatitis C.

In addition, a list has been provided to general practices of their enrolled patients who have previously had a positive antibody result. This list enables practices to recall these patients.  

Patient pathway

Patients who have a positive antibody test (whether by point of care testing or venepuncture) will need to have a PCR (viral load) blood test. If this is positive, they will need to be referred for a Fibroscan and/or have an APRI blood test in order to determine the course of treatment. Patients with no or minimal fibrosis on Fibroscan or APRI may be referred back to general practice for the prescription of treatment. All other patients will be managed in secondary care. 

Additional patient funding

Any person with a community services card can apply to WINZ for a special grant to assist with their treatment costs. They do not need to pay this money back. They require confirmation of the fact they are eligible for hepatitis C treatment along with an indication of travel costs to access the GP.  

This can also cover any additional GP visits beyond the funded consultations provided by this service. 

Who is excluded from the service?

Patients already receiving hepatitis C treatment from secondary care. 

When is the service completed?

The package of care is outlined in the claiming guidelines. 

There is only one of each consultation type funded per patient. 

Claiming guidelines

No patient co-payment can be charged for any of the funded consultations. 

One of each consultation type per patient – please refer to flow chart under service components.  

Prices listed below are GST inclusive. 

Initial contact: 15 minutes - $20.13 
Discussion with patient, antibody test ordered and recorded.       

Initial consult: 30 minutes - $43.13 
PCR ordered and recorded, APRI recorded, Fibroscan ordered prn.        

Prescriber consult: 30 minutes - $86.25 
Prescribe treatment, will need phone calls to order bloods, to monitor side effects and check adherence.           

Follow up consult: 30 minutes - $43.13 
Face to face 12 weeks after treatment completed, repeat bloods. 

  • A claim form is loaded into your PMS. 
  • In Indici the service will be visible under funded services to the right of your patient palette.  
  • In MedTech the service can be accessed via an advanced form. 
  • Submission of the form will generate a claim. Completion of the claim form is sufficient documentation to lodge a claim.  
What level of clinical notes do I need to submit?

Practices are required to provide sufficiently detailed consultation notes to determine appropriate use of funding.  

Does the patient have to pay?

No patient co-payment can be charged for any of the funded consultations. 

Any person with a community services card can apply to WINZ for a special grant to assist with their treatment costs. They do not need to pay this money back. They require confirmation of the fact they are eligible for hepatitis C treatment along with an indication of travel costs to access the GP.  

This can also cover any additional GP visits beyond the funded consultations provided by this service. 

How is the service funded?

The service is funded by Te Whatu Ora.  

Contact

Sally Newell, Regional Support Manager - Clinical Contracts
sally.newell@pinnacle.health.nz
021 150 8788

YOU MAY ALSO BE INTERESTED IN
PIN POINTS
Pathlab: Hepatitis B serological testing update
Lakes | Waikato | Clinical | 04/12/2024

Pathlab has reviewed Hepatitis B serology requesting. Due to the range of serological assays that can be requested for this infection, this can be a potentially confusing area for both requestors and the laboratory receiving the requests. With this in mind, Pathlab has put together some brief guidance.

Read more
PROGRAMMES
Abdominal pain (POAC)
Lakes | Gastroenterology | Under 18 | Over 18 | Over 65

Treatment of patients with abdominal pain, who are haemodynamically stable.

View details
RESOURCE
Identifying the risk of serious illness in children with fever
Published: 19/06/2024 | 1 link | Document

This BPAC resource assists to predict risk of serious illness in children with fever

View resource
Taranaki
47 Molesworth Street
New Plymouth 4310
+64 6 759 4364
Tairāwhiti
Level 1
295-299 Gladstone Road (entrance via Cobden Street)
Gisborne 4010
PO Box 1188
Gisborne 4040
06 863 2661
Lakes
Level 1
95 Te Heuheu Street
Taupō 3330
PO Box 1716
Taupō 3351
+64 7 376 0060
Waikato
Norris Ward McKinnon House
Level 3
711 Victoria Street
Hamilton 3204
PO Box 983
Hamilton 3240
+64 7 839 2888
Facebook @PinnacleIncorporated LinkedIn midlands-health-network
Copyright © 2025 Pinnacle Incorporated
Privacy policy Terms & conditions Practice update dashboard
Copyright © 2025 Pinnacle Incorporated
Privacy policy Terms & conditions Practice update dashboard